Published in J Burn Care Rehabil on December 11, 2001
State of the art in burn treatment. World J Surg (2005) 1.88
Association of increasing burn severity in mice with delayed mobilization of circulating angiogenic cells. Arch Surg (2010) 1.60
A protocol for resuscitation of severe burn patients guided by transpulmonary thermodilution and lactate levels: a 3-year prospective cohort study. Crit Care (2013) 1.19
Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds. J Mol Med (Berl) (2011) 0.96
Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair Regen (2011) 0.93
Morphological parameters for assessment of burn severity in an acute burn injury rat model. Int J Exp Pathol (2009) 0.87
Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells. Cardiovasc Res (2011) 0.86
Current concepts on burn wound conversion-A review of recent advances in understanding the secondary progressions of burns. Burns (2016) 0.76
Expression and activity levels of chymase in mast cells of burn wound tissues increase during the healing process in a hamster model. Exp Ther Med (2015) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2000) 4.89
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg (1995) 3.41
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
The meaning and structure of species as applied to mycobacteria. Tubercle (1974) 3.22
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Give us this day our daily germs. Immunol Today (1998) 3.19
Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (2001) 3.00
Mycobacteria as a possible cause of inflammatory bowel disease. Lancet (1978) 2.94
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Estimating the risk of breast cancer in relation to the interval since last term pregnancy. Epidemiology (1997) 2.72
A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol (1972) 2.63
Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst (1999) 2.59
Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst (2001) 2.46
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle (1981) 2.34
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci (1995) 2.25
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet (1999) 2.12
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst (2001) 2.09
Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst (2000) 2.07
A preliminary report on some studies of environmental mycobacteria. Ann Soc Belg Med Trop (1973) 2.06
Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet (1994) 2.06
Multiple skin testing in leprosy. J Hyg (Lond) (1975) 2.04
The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. J Hyg (Lond) (1975) 2.02
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol (2001) 1.86
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol (1969) 1.80
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev (2001) 1.79
Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care (1999) 1.77
BCG vaccination and cancer. Tubercle (1990) 1.76
An immunodiffusion analysis of strains of Mycobacterium ulcerans isolated in Australia, Malaya, Mexico, Uganda and Zaire. J Med Microbiol (1973) 1.76
Body size and breast cancer risk among women under age 45 years. Am J Epidemiol (1996) 1.75
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
EFFECT OF INSULIN HYPOGLYCEMIA AND GLUCOSE ADMINISTRATION ON THE LEVEL OF THE GLUTAMINE-LIKE SUBSTANCE IN BLOOD SERUM. J Clin Invest (1943) 1.70
Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis (1973) 1.70
Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68
A co-operative numerical analysis of nonscoto- and nonphotochromogenic slowly growing mycobacteria. J Gen Microbiol (1974) 1.64
Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia (2007) 1.60
Dietary relationships with early onset (under age 45) breast cancer in a case-control study in the United States: influence of chemotherapy treatment. Cancer Causes Control (1997) 1.59
Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet (2000) 1.58
Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol (1988) 1.56
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol (1999) 1.56
Serological and bacteriological investigation of Mycobacterium ranae (fortuitum). J Bacteriol (1969) 1.55
Studies of mycobacterial antigens, with special reference to Mycobacterium leprae. Infect Immun (1976) 1.55
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol (1995) 1.53
Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol (1988) 1.53
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
A study of Mycobacterium fortuitum (ranae). J Med Microbiol (1974) 1.51
Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection. J Hyg (Lond) (1977) 1.50
Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst (1995) 1.50
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol (2001) 1.46
Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43
Studies on Mycobacterium chelonei. J Med Microbiol (1972) 1.40
Immunodiffusion analysis--a rational basis for the taxonomy of mycobacteria. Ann Soc Belg Med Trop (1973) 1.40
The mycolic acids of Mycobacterium chelonei. J Gen Microbiol (1982) 1.39
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. Br J Cancer (2007) 1.38
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38
Sexual factors and the risk of prostate cancer. Am J Epidemiol (2001) 1.38
Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study. Med Care (2000) 1.36
Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol (1997) 1.35
Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins. J Hyg (Lond) (1975) 1.34
An antigenic analysis of the mycobacteria, Mycobacterium fortuitum, Myco. kansasii, Myco. phlei, Myco. smegmatis and Myco. tuberculosis. J Pathol Bacteriol (1968) 1.33
Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet (1999) 1.30
Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patients. Clin Exp Immunol (1976) 1.30
Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer (2001) 1.29
Immunodiffusion analysis shows that Mycobacterium paratuberculosis and other mycobactin-dependent mycobacteria are variants of Mycobacterium avium. J Appl Bacteriol (1986) 1.28
Slow bacterial infections or autoimmunity? Immunol Today (1992) 1.28
Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol (1986) 1.28
Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol (1996) 1.28
Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia (2008) 1.27
Diet during adolescence and risk of breast cancer among young women. J Natl Cancer Inst (1998) 1.27
Germ-line BRCA1 mutations in selected men with prostate cancer. Am J Hum Genet (1996) 1.26
Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.24
Rifampicin in experimental Mycobacterium ulcerans infection. J Med Microbiol (1972) 1.24
Occurrence of breast cancer in relation to recreational exercise in women age 50-64 years. Epidemiology (1996) 1.23
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle (1981) 1.22
Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy. Epidemiol Infect (2001) 1.22
Laser Doppler imaging determines need for excision and grafting in advance of clinical judgment: a prospective blinded trial. Burns (2003) 1.21
A preliminary study of delayed hypersensitivity to Mycobacterium chelonei, Mycobacterium fortuitum (Ranae) and Mycobacterium gordonae in cattle from two areas in Uganda. Br J Exp Pathol (1974) 1.21
Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol (1997) 1.20
Taxonomic studies on the leprosy bacillus. Int J Lepr Other Mycobact Dis (1976) 1.19
HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18